1968
DOI: 10.1016/0002-9378(68)90323-2
|View full text |Cite
|
Sign up to set email alerts
|

Effects of adrenergic blocking agents and catecholarnines in human pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
9
0

Year Published

1970
1970
1988
1988

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(9 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…Norepinephrine, on the other hand, promotes an increase of uterine motility (15). It is also established that catecholamine levels tend to be elevated during stressful situations (7).…”
mentioning
confidence: 99%
“…Norepinephrine, on the other hand, promotes an increase of uterine motility (15). It is also established that catecholamine levels tend to be elevated during stressful situations (7).…”
mentioning
confidence: 99%
“…,p-Adrenoceptor blocking drugs ((3-blockers) have been used, together with catecholamines to aid in the control of uterine contractions during pregnancy Barden & Stander, 1968). Coincident with their use in pregnancy, questions arise regarding the effects these 8-blockers may have on the foetus.…”
Section: Introductionmentioning
confidence: 99%
“…The main effects seen in the neonate are low birthweight (Reed et al, 1974;Oakley et al, 1979) possibly owing to inadequate perfusion of the fetal side of the placenta (Barden and Stander, 1968), hypoglycaemia and bradycardia (Habib and McCarthy, 1977;Cottrill et al, 1977), and respiratory depression (Tunstall, 1969). However, other workers have given r-adrenoceptor antagonists to pregnant women with no ill effects on mother or child (Tcherdakoff et al, 1978;Gallery et al, 1978;Dubois et al, 1978).…”
Section: Introductionmentioning
confidence: 99%